RBC Raises Price Target on Mind Medicine (MindMed) to $7 From $5, Maintains Outperform, Speculative Risk
RBC Raises Price Target on Mind Medicine (MindMed) to $7 From $5, Maintains Outperform, Speculative Risk
加拿大皇家銀行將心靈醫學（MindMed）的目標股價從5美元上調至7美元，維持投機風險跑贏大盤
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊